# Contribution of Hyperinsulinemia vs. Hyperglycemia to Insulin Resistance in Type 1 Diabetes and Maturity Onset Diabetes of the Young, Type 2 (MODY2)

> **NCT02971202** · PHASE1 · COMPLETED · sponsor: **Vanderbilt University** · enrollment: 33 (actual)

## Conditions studied

- Type 1 Diabetes Mellitus
- Maturity-Onset Diabetes of the Young, Type 2
- MODY2
- Insulin Resistance

## Interventions

- **DRUG:** Hyperinsulinemic, euglycemic clamp
- **DRUG:** 20% dextrose

## Key facts

- **NCT ID:** NCT02971202
- **Lead sponsor:** Vanderbilt University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-12
- **Primary completion:** 2019-02
- **Final completion:** 2019-02
- **Target enrollment:** 33 (ACTUAL)
- **Last updated:** 2019-08-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02971202

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02971202, "Contribution of Hyperinsulinemia vs. Hyperglycemia to Insulin Resistance in Type 1 Diabetes and Maturity Onset Diabetes of the Young, Type 2 (MODY2)". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT02971202. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*